Pipeline
Ziphius aims to leverage its self-amplifying mRNA platform to create vaccines for the prevention of infectious diseases. Currently, Ziphius focusses on three areas of infectious diseases: airborne, mucosal-borne and vector-borne diseases.
Ziphius aims to leverage its self-amplifying mRNA platform to create vaccines for the prevention of infectious diseases. Currently, Ziphius focusses on three areas of infectious diseases: airborne, mucosal-borne and vector-borne diseases.